Bionic Eye Technologies Overview
- Founded
-
2012
- Status
-
Private
- Latest Deal Type
-
Corporate
- Financing Rounds
-
1
Bionic Eye Technologies General Information
Description
Developer and manufacturer of medical devices designed to assist visually impaired patients. The company's products include retinal prosthesis that is used in the sub-retinal area of the eye and provides lower risk of eye infection, reduced erosion through the delicate tissues that cover the front of the eye and the ability to place stimulating electrodes closer to retinal nerve cells, enabling the patients to enhance visual outcomes.
Contact Information
Website
www.bionicvisiontechnologies.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Primary Office
- 239 Cherry Street
- Suite 1B
- Ithaca, NY 14850
- United States
+1 (607) 000-0000
Bionic Eye Technologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bionic Eye Technologies Patents
Bionic Eye Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10967172-B1 | Method and apparatus for minimally-invasive implantation of electrodes and flexible, thin-film substrates into cortical or sub-cortical structures of the brain | Active | 27-Dec-2018 | 00000000000 | 00 |
Bionic Eye Technologies Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Douglas Shire Ph.D | Chief Technology Officer | ||
| Joseph Rizzo III | Co-Founder & Medical Director | ||
| John Wyatt Ph.D | Co-Founder |
Bionic Eye Technologies Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|